Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0LMSXT
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
Recombinant chimeric anti-CD30 mAb-MCC-DM1
|
|||||
| Organization |
Shanghai Jiaolian Drug Development Co. Ltd.; Shanghai Fudan Zhangjiang Bio Pharmaceutical Co., Ltd.; Shanghai Pharmaceutical (Group) Co., Ltd.
|
|||||
| Drug Status |
Phase 1
|
|||||
| Indication |
In total 1 Indication(s)
Hematologic cancer [ICD11:2B3Z]
Phase 1
|
|||||
| Antibody Name |
Undisclosed
|
|||||
| Antigen Name |
Tumor necrosis factor receptor superfamily member 8 (TNFRSF8)
|
Antigen Info | ||||
| Payload Name |
Undisclosed
|
|||||
| Linker Name |
Undisclosed
|
|||||
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.